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Abstract
Background: Increasingly, evidence-based health information, in particular evidence from systematic reviews, is being
made available to lay audiences, in addition to health professionals. Research efforts have focused on different formats
for the lay presentation of health information. However, there is a paucity of data on how patients integrate evidence-
based health information with other factors such as their preferences for information and experiences with information-
seeking. The aim of this project is to explore how people with multiple sclerosis (MS) integrate health information with
their needs, experiences, preferences and values and how these factors can be incorporated into an online resource of
evidence-based health information provision for people with MS and their families.
Methods: This project is an Australian-Italian collaboration between researchers, MS societies and people with MS.
Using a four-stage mixed methods design, a model will be developed for presenting evidence-based health
information on the Internet for people with MS and their families. This evidence-based health information will draw
upon systematic reviews of MS interventions from The Cochrane Library. Each stage of the project will build on the last.
After conducting focus groups with people with MS and their family members (Stage 1), we will develop a model for
summarising and presenting Cochrane MS reviews that is integrated with supporting information to aid understanding
and decision making. This will be reviewed and finalised with people with MS, family members, health professionals
and MS Society staff (Stage 2), before being uploaded to the Internet and evaluated (Stages 3 and 4).
Discussion: This project aims to produce accessible and meaningful evidence-based health information about MS
for use in the varied decision making and management situations people encounter in everyday life. It is expected
that the findings will be relevant to broader efforts to provide evidence-based health information for patients and
the general public. The international collaboration also permits exploration of cultural differences that could inform
international practice.
Keywords: Evidence-based patient information, Consumer involvement, Knowledge translation, Multiple sclerosis,
Internet, Self-management, Preferences
Background
Evidence-based health information for patients
Systematic reviews represent the highest level of evi-
dence of the effectiveness of health care interventions
[1]. Historically, it has been clinicians who have used
evidence from systematic reviews of controlled trials to
stay abreast of current research and inform their prac-
tice [2]. Increasingly, however, evidence-based health
information, including systematic reviews, is also being
provided to lay audiences [3].
Ar e c o g n i s e ds o u r c eo fh i g hq u a l i t ye v i d e n c ei st h e
Cochrane Collaboration [4]. Cochrane systematic
reviews summarise evidence from trials on the effects of
treatments (medicines, surgery, rehabilitation), and
behavioural and informational interventions. These
reviews are the most rigorous summary of the evidence
* Correspondence: Sophie.hill@latrobe.edu.au
1Centre for Health Communication and Participation, Australian Institute for
Primary Care and Ageing, La Trobe University, Melbourne, Australia
Full list of author information is available at the end of the article
Hill et al. BMC Medical Informatics and Decision Making 2012, 12:20
http://www.biomedcentral.com/1472-6947/12/20
© 2012 Hill et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.available. They are kept up-to-date, with new evidence
added every few years [4]. In Australia, as in many parts
of the world, Cochrane systematic reviews are available
free to the public because of a nationally-funded sub-
scription to The Cochrane Library [5]. In Italy, Italian
translations of selected plain language summaries of
Cochrane reviews are available free to the public on the
PartecipaSalute web site [6] and in the “SM Italia” jour-
nal of the Associazione Italiana Sclerosi Multipla
(AISM).
Research has shown that evidence-based health infor-
mation may improve people’s knowledge, capacity to
manage their health, and their health literacy [7,8]. An
overview of more than 50 systematic reviews demon-
strated a range of positive effects that may stem from
informing and educating people about their health, and
involving them in the management of their health [7].
The authors concluded that informational interventions,
in conjunction with professional advice, can improve
people’s health literacy: effects include improvement in
health knowledge and recall, reduced anxiety, improved
symptom management, and an increased sense of
empowerment. Examples of interventions that were
shown to improve patient health literacy include well-
designed and written health information and educational
support materials, computer-based and Internet-based
information resources, and targeted mass-media
approaches for specific population groups [7].
Research into accessible and usable formats for com-
municating evidence to lay audiences has flowed from
these initiatives and has focused primarily on how to
present evidence-based information clearly and unam-
biguously [9,10]. This is vital in order to avoid the non-
transparent framing of risk and benefit information, and
the associated consequences of unintended or intended
manipulation of risk information [11,12]. The results of
such studies are promising. For example, a randomised
controlled trial of a drug leaflet advertisement that
included a fact box about the medicine (quantifying out-
comes with and without the drug) showed that the
intervention improved patients’ knowledge of drug bene-
fits and side effects, resulted in better choices of drugs
for symptoms, and improved patients’ ability to make a
realistic assessment of benefits, compared with a drug
advertisement without the fact box [13].
Health information and people with multiple sclerosis
Developments in the delivery of evidence-based health
information have critical implications for providing infor-
mation to people with multiple sclerosis (MS). Research
has demonstrated that information plays an important
role for people with MS to help them understand their
diagnosis and treatments, and for self-management edu-
cation [14,15]. MS is a complex inflammatory disease of
the central nervous system, characterised by progressive
neurological dysfunction, for which both a cure and the
cause remain elusive. MS affects about 2.5 million indivi-
duals throughout the world [16]. Diagnosis typically
occurs between the ages of 20 and 40. People with MS
are high users of the full range of health services and, in
particular, of medicines [17]. Despite the fears and anxi-
eties that may arise from learning about the disease, the
treatments, and self-management strategies, Wollin et al.
[14] conclude that information is a critical component
for informed decision making, problem solving, and self-
determination.
The advent of disease-modifying drugs for MS means
that people are actively seeking information about new
treatments, and earlier attitudes of hopelessness are
changing [18]. German research has found that people
with MS were seeking more information than was pro-
vided at the time of their diagnosis, including informa-
tion about potential treatments [18]. Later studies
identified that people were requesting active roles with
regard to medical decision making, and that they under-
stood complex health and research information [19,20].
This finding opens up the possibility of shared decision
making between patients and doctors about treatment
options and health management.
Concurrently, the information-seeking landscape has
changed dramatically with the addition of the Internet,
which can facilitate greater opportunities for shared
decision making. While medical professionals and MS
societies have long been the preferred and trusted
sources of health information, the Internet is gaining
increasing prominence, particularly amongst younger
people [21]. Studies conducted in Israel and the US
found that between 64% and 82% of people with MS
seek health information online [21,22].
In many countries, non-government organisations such
as MS societies play a critical role in providing informa-
tion for people with MS [23] and are using their web
sites to provide information to people or to refer them to
other high-quality sources. The move to online technolo-
gies reflects consumer demand and a population need to
foster confident and skilled users of information. It is
also fulfilling non-government organisations’ roles to
promote a higher level of client and community engage-
ment in health care and service models, and to support
policy for public participation in the health service sys-
tem [24,25]. Users of non-government web sites are not
only consumers. Health professionals play two important
roles in people’s Internet-based health-information seek-
ing: 1) they may work in partnership with patients and
patient groups to obtain and analyse information, and 2)
they can guide Internet users toward reliable health
information web sites [26]. The development of
high quality, evidence-based health information on
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different user groups and their needs.
Making evidence meaningful for people
Our assertion is two-fold. First, that people with MS
who read summaries of systematic reviews for health
information may need additional documented support
or advice to help them understand how the information
can be applied to their personal context [14,27]. This
documentation may also support people to use the
information in the systematic reviews when making
decisions and judgements with their doctors about treat-
ment preferences or self-management options that will
work for them. There is a paucity of data about the
experiences people have when needing to assess evi-
dence-based information and integrate it into their own
context and value system. The second part of our asser-
tion addresses the process of developing complex inter-
ventions, such as health information services for
patients. In order to supply a service that is applicable
to a population group, the information and other needs
of those individuals must first be understood. The next
steps are to identify the evidence base, build or refine
the theoretical concepts, then evaluate the processes and
outcomes for implementation, before trialling the inter-
vention [28].
We know that many patients and family members
want to understand the evidence that supports treat-
ment options [10]. They also want to know how the
research relates to them individually [29], as well as the
implications of the findings for their future treatment
choices and management options. This creates a chal-
lenge for services that provide health information based
on research because that information may not be suffi-
cient for an individual to make the connection between
the research and their own circumstances. Further infor-
mation may need to be provided by the health informa-
t i o ns e r v i c ei no r d e rf o rp e o p l et ob ea b l et om a k e
judgements about the appropriateness of a treatment for
their own context. Furthermore, as new research is con-
ducted, people may need to understand how new infor-
mation relates to what they already know. For example,
they may need to decide if a new treatment would be
substantially better for them, maybe with reduced risks
or adverse effects, compared with their current options.
The aim of this project is 1) to explore how people
with MS assess and integrate health information into
their lives according to their needs, experiences, prefer-
ences, and values, and 2) how documentation to support
people to make the connection between health informa-
tion and their needs, experiences, preferences and values
can be provided in an online resource of evidence-based
health information for people with MS, and their
families.
Methods
This project will employ a mixed methods approach
involving four stages: qualitative research (Stage 1);
action research (Stage 2); operational research (Stage 3);
and evaluation (Stage 4) (see Figure 1). A mixed meth-
ods study combines and builds knowledge derived from
qualitative and quantitative research methods [30]. It
aims to generate theory and test it in latter stages.
The IN-DEEP project (Integrating and deriving evi-
dence, experiences and preferences: Developing evi-
dence-based health information applicable to decision
making and self-management by people with MS) is a
collaboration of project teams in Melbourne, Australia
(led by SH) and Milan, Italy (led by GF). It will be con-
ducted in parallel in Australia and Italy. The studies will
be conducted as stand-alone projects but will follow the
same stages and mixed methods approach. We antici-
pate some methodological differences between the pro-
jects as we progress due to differing findings from early
research stages and contextual differences between
countries. A comparison of similarities and differences
in project findings between Australia and Italy will be
considered at each stage and will be reported.
Advisory groups
Prior to the commencement of the research, an Italian
and an Australian advisory group will be formed. The
advisory groups at each site will play key roles in guid-
ing all project stages and will include members of the
local research teams, local MS society staff (MS Austra-
lia in Australia and AISM in Italy), and people with MS.
Academic-community partnerships benefit from the dif-
ferent perspectives and organisational styles [31]. Addi-
tionally, there is strong evidence that involving patients
in the development of health information leads to infor-
mation that is more understandable [32].
Participants
People with MS, and family members of people with MS
People with MS, and family members (partners, parents,
children and siblings aged over 18) of people with MS
will be included in the study. It is often the case that
c l o s ef a m i l ym e m b e r sm a yb ea so rm o r ea c t i v e l y
involved in finding and assessing health information as
the person with MS. To reflect the gender and age dis-
tribution of people with MS, we will aim to include
women with MS in an approximate 3:1 ratio to men,
and include participants in the age range of 20-69 [17].
Individuals outside that range (over 18 years) if they are
interested to participate will also be accepted. A mix of
people newly diagnosed with MS (up to three years
since diagnosis), those with later stages of MS (living
with MS for at least 4 years), and people taking immu-
notherapy medications will also be sought in order to
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and family members of people with MS will be invited
to take part in all four stages of the research.
MS society staff and health professionals
As well as including people with MS and their family
members, Stages 2 and 3 will also include clinicians
involved with MS treatment, and MS society staff who
work in a health information capacity. The involvement
of participants from a variety of perspectives means that
the research can gain insight into a range of potential
barriers to uptake of information from an online
resource, and then be able to take steps to reduce these
barriers in practice.
Participant sampling
Purposive sampling will be used both in Australia and
Italy. People with MS, family members, and health pro-
fessionals will be recruited using the communication
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Figure 1 Flow chart of IN-DEEP project.
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Italy and their networks of related organisations. In Aus-
tralia, snowball sampling from the pool of people with
MS and family members will also be undertaken, while
in Italy collaborating neurologists will identify eligible
patients with MS and family members. From these pools
of participants, selected participants will be invited to
take part in focus groups and the successive stages of
the study.
Research activities
Stage 1: Qualitative research
The aim of Stage 1 is to document and analyse the
needs, experiences, preferences, and values of people
with MS when assessing and integrating evidence-based
health information into their decision-making about,
and management of, their health. Between four and six
focus groups will be conducted in each country. In Aus-
tralia, focus groups will be held in Victoria and Tasma-
nia, with at least one in a non-metropolitan area. In
Italy, focus groups will be conducted in Northern, Cen-
tral and Southern Italy. Where possible, groups will be
stratified according to length of time since diagnosis and
whether or not participants are a person with MS or a
family member. The focus groups will last approxi-
mately one hour and will be conducted by two experi-
enced researchers. The focus groups will be audio-
recorded and transcribed verbatim.
Focus group topics will be based on four main ques-
tions: (1) Where do you get reliable information about
the evidence of the effectiveness of treatments for MS?;
(2) What kinds of information do you need, and how do
these needs change over time?; (3) How do you use the
Internet to access information about treatments for
MS?; and (4) How do you assess the quality and useful-
ness of this information?
The focus group transcripts will be analysed by the-
matic analysis. Two researchers will independently read
the transcripts multiple times and identify emerging
themes. Agreed codes will be used to categorise the
themes.
Stage 2: Action research
The aim of Stage 2 is to use the data from Stage 1 to
generate a model that will guide the study team to
develop evidence-based health information that is mean-
ingful for people with MS and their family members,
and that people can apply to their own situations. To do
this, we will develop a template for summarising and
presenting evidence-based health information (evidence
summaries), which will be connected to supporting doc-
umentation to help people understand the summarised
evidence, apply it to their personal circumstances, and
use it when making health-related decisions. The exact
nature of the evidence summaries and supporting
documents will be fine-tuned in workshops (review
panels) with people with MS, family members, health
professionals and MS Society staff. Action research is
used when the aim of the study is to both generate
knowledge about a social system and, at the same time,
attempt to change that system [33].
The evidence summaries will be created using a selec-
tion of systematic reviews of MS intervention effective-
ness from T h eC o c h r a n eL i b r a r y . As at Issue 1, 2012 of
The Cochrane Library, there were 36 published reviews
about MS interventions, including reviews of medicines
(such as corticosteroids and interferons) and other inter-
ventions (such as rehabilitation, diet, and allied thera-
pies). These reviews are coordinated by the MS
Cochrane Review Group, led by GF as the Coordinating
Editor. Summaries will be prepared in English and Ita-
lian. Consideration will be given to information needs
that are not met by Cochrane reviews.
The evidence summaries and supporting materials will
be developed based on methods for presenting evidence
to patients that have been identified in the literature.
These summaries will be integrated with supporting
documentation that is relevant to understanding evi-
dence and to personal decision making, and will be
informed by the themes that arose in Stage 1.
Two review panels per country will be held. The
review panels will operate like focus groups but will
have an element of ‘review’, which means a range of for-
mats for presenting health information can emerge and
be discussed and debated. The results of the panel meet-
ings will be analysed by examining the themes discussed,
participant comments, areas of agreement, and decisions
made. The results will be discussed by the project team,
and taken to the advisory group for consideration. The
project team will consider any divergence between the
Australian and Italian panels and the implications of
these for the online resource.
Stage 3: Operational research
The aim of Stage 3 is to establish a model for presenting
evidence-based health information (the evidence sum-
maries and supporting documentation developed in
Stage 2) on the Internet. This stage involves undertaking
operational research, which is a method for linking
research to practice, and for examining processes and
outcomes for implementation [28,34].
The project team and advisory group will model, plan
and create the online information resource, using the out-
puts of Stages 1 and 2. A protocol and guidelines for how
the project team, MS society staff and people with MS can
contribute to the development and maintenance of the
documents for the online resource will also be created.
Stage 4: Evaluation
The aim of Stage 4 is to evaluate whether or not the IN-
DEEP online resource meets the needs of people with
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ing to the information gathered in Stage 1. In broad
terms, the evaluation will undertake usability, need,
health literacy, and quality assessments. This means the
evaluation will assess people’se x p e r i e n c eo fu s i n gt h e
online health information resource; verify whether or
not the information on the web site fulfils people’s
information needs; determine if people can understand
and plan to use the information when making health-
related decisions; and find out if people consider the
information to be of good quality.
For the evaluation we will review the IN-DEEP project
intended outcomes; develop an evaluation framework to
summarise the project expectations and outline the
steps of the evaluation; document deviations from the
initial protocol; develop and pre-test an online question-
naire using evidence-based techniques; provide the final
questionnaire for online use; analyse the results of the
questionnaire; and report on the evaluation findings. An
online questionnaire represents a low-cost but effective
method for obtaining evaluation data [35]. Additionally,
Internet-tracking tools will be utilised to keep a record
of the number of ‘hits’ on the site. The evaluation
results will be used to make recommendations to
improve the online resource.
Ethical considerations
Written, informed consent will be sought from all partici-
pants prior to their taking part in the study. Ethical
approval has been granted by the Faculty of Health
Sciences Human Research Ethics Committee of La Trobe
University, Australia, and the Ethics Committee of the Fon-
dazione IRCCS Istituto Neurologico “Carlo Besta”,I t a l y .
Discussion
The IN-DEEP project will develop a sound and theoreti-
cally informed online model that makes evidence-based
health information accessible and understandable for
people with MS and family members. The evidence-
based research information will be supported by docu-
mentation that is reflective of people’sn e e d s ,e x p e r i -
ences, preferences and values, and will help people to
integrate the research information into, and apply it to,
their own circumstances.
The lack of carefully grounded consultations when
developing health information has been a major gap in
this area in the past [36]. The consultations for the IN-
DEEP project will involve two main dimensions: the first
is to undergo consultations with people with MS, their
families, and health professionals associated with MS in
order to identify the perceived gaps in information for
treatments and self-management; and the second is to
identify ways in which evidence-based research can be
presented on the Internet to support people to make
health-related decisions about treatments and self-man-
agement options.
This research will be cognisant of the challenges that
people with low health literacy have. Health literacy
encompasses ideas around a person’s ability to access,
understand and use health information relevant to their
situation [8]. Australian research about the experience
of living with MS illuminates a wider context for the
need to make health information accessible and under-
standable. MS has pervasive and disabling effects on a
person’s life and that of their family [17,37]. Research
into the support needs for someone with MS highlights
the variable and ongoing nature of the demands placed
on individuals and their families [38]. Individuals’ stoi-
cism and coping strategies need to be recognised and
supported so that people can plan for and manage their
health, and communicate their problems to family and
health professionals. By making health information more
understandable (evidence summaries) and accessible
(available on the Internet), the IN-DEEP project seeks to
increase the confidence of people with MS to access,
understand and use new research and information about
MS management and treatment that they may come
across in the media or on the Internet. The IN-DEEP
online health-information resource will provide accessi-
ble information about the effects of clinical, educational
and behavioural interventions for MS.
A ni m p o r t a n ta s p e c to ft h eI N - D E E Pr e s e a r c hi st h e
opportunity to compare differences between two coun-
tries when developing health-related information and
the platform from which to provide that information to
consumers. Routinely, research summaries are translated
verbatim where possible for publication on non-English
web sites. The IN-DEEP research will enable us to
examine if there are key differences between English
and non-English versions of health-related information
that could inform international practice.
This research is at the forefront of international efforts
to improve the quality and relevance of evidence-based
i n f o r m a t i o nf o ru s eb yp e o p l ew i t hM S ,a n dt op a t i e n t s
and their families/carers more widely. People with MS
are not only users of health information, they are future
drivers of policies for a more responsive health care sys-
tem [39]. Due to the demands of illness, people with
MS and their families have to become skilled users of
information, and able to find support when needed. In
recognition of this, this project will involve people with
MS, their families, health professionals and non-govern-
ment organisations in a partnership model for the co-
production of new knowledge and resources [40].
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